Overview
Ameloblastoma is a benign but locally aggressive odontogenic tumor arising from the mandible or maxilla, characterized by its potential for recurrence if not adequately managed. It can present in various forms, including intraosseous, extraosseous, and rarely, with atypical features such as vascularization or malignant transformation 134.Diagnosis
Clinical Presentation: Often presents as a painless swelling in the jaw 13.
Imaging: Radiographic evaluation (CT, MRI) crucial for assessing extent and invasion 15.
Fine-Needle Aspiration: Bloody return does not exclude ameloblastoma; histopathological confirmation required 1.
Histopathology: Essential for definitive diagnosis, distinguishing from other odontogenic tumors 13.
Grading: WHO classification system grades ameloblastoma based on histological aggressiveness (Solid, Unicystic, and Peripheral types) 13.Management
Surgical Excision: Wide local excision with clear margins is the mainstay of treatment 13.
Reconstruction: Often required post-excision to restore function and aesthetics 13.
Adjuvant Therapy: Not typically indicated for benign ameloblastoma 2.
Monitoring: Regular follow-up imaging and clinical examination to detect recurrence 13.
Metastatic Cases: Management of metastatic disease (e.g., pulmonary metastases) may involve systemic therapy, though specific drug classes/doses are not detailed in the abstracts 24.Special Populations
Pregnancy: No specific guidelines provided in the abstracts; management likely similar to non-pregnant patients with careful surgical planning [Expert opinion].
Pediatrics: Extraosseous ameloblastoma can occur; management focuses on conservative surgical excision to avoid recurrence 3.
Elderly: Considerations for surgical risk and functional outcomes are paramount; individualized treatment plans recommended [Expert opinion].
Comorbidities: Presence of comorbidities may influence surgical approach and postoperative care; tailored management strategies advised [Expert opinion].Key Recommendations
Fine-needle aspiration with bloody return should not preclude ameloblastoma diagnosis; histopathological examination is mandatory (Evidence: Moderate 1).
Wide local excision with clear margins is essential for preventing recurrence in ameloblastoma management (Evidence: Moderate 13).
Regular follow-up is crucial for early detection of recurrence, especially in high-risk cases (Evidence: Expert opinion).
In cases of metastatic ameloblastoma, multidisciplinary management including potential systemic therapy should be considered (Evidence: Weak 24).References
1 Childers ELB, Taddasse-Heath L, Bonnick A, Naab T. Vascularized ameloblastoma: A case report and clinicopathologic review of 18 cases from the literature. Oral surgery, oral medicine, oral pathology and oral radiology 2020. link
2 Newman L, Howells GL, Coghlan KM, DiBiase A, Williams DM. Malignant ameloblastoma revisited. The British journal of oral & maxillofacial surgery 1995. link90087-x)
3 Chan MF, Cassidy M, High AS. Ameloblastoma of attached gingiva. British dental journal 1994. link
4 Harada K, Suda S, Kayano T, Nagura H, Enomoto S. Ameloblastoma with metastasis to the lung and associated hypercalcemia. Journal of oral and maxillofacial surgery : official journal of the American Association of Oral and Maxillofacial Surgeons 1989. link90187-0)
5 Siar CH, Ng KH. Residual cyst: an incidental finding during alveolectomy. Dental journal of Malaysia 1987. link